We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Independent Medical Education

Genentech supports grants for independent medical education in an effort to advance excellence in medicine and healthcare and improve patient health outcomes by enhancing the knowledge of the medical community.

Important Notice

Genentech is committed to supporting our existing grantees during the evolving coronavirus (COVID-19) pandemic. We understand that grantees will have their own challenges in adapting to rapidly changing events, and we will work to accommodate needs for the programs funded by Genentech.

If you are an existing grantee, please contact your Genentech representative with questions or to let us know if your program or event will be cancelled or postponed. If you are unsure of who to contact, please email [email protected] and we will direct you to the appropriate person.

To learn more about Genentech’s efforts during the pandemic, please visit our COVID-19 response page.

Independent Medical Education (IME) is generally defined as education for healthcare professionals (HCPs) provided by an independent educational provider, such as a community hospital, academic center, society/association or medical education and communication company.

Call for Grants

Genentech is actively seeking applications for independent medical education.

Click on a link below for more information and detailed instructions on submitting a Call for Grant Notification (CGN) application.

  • NEW! Independent Medical Education CGN Application - TIGIT CGN (full applications due November 29, 2021).
  • NEW! Independent Medical Education CGN Application – DLBCL (Final submission into grant system due on November 30, 2021)

NOTE: Our online grant system continues to be open to accepting applications for all therapeutic areas.

An organization with a written policy to discriminate based on race, religion, gender, gender expression and/or identity, age, national origin, disability, marital status, sexual orientation, military status, or any other protected status is ineligible for funding.

Decision Making

Call for Grant Notifications (CGNs) have specified deadlines for application submission and will be posted on this website periodically throughout the year. For other funding requests, Genentech has a rolling review policy when evaluating funding requests for independent medical education, which means that we do not have a specific deadline for which funding requests must be received. This allows qualified requestors the opportunity to apply anytime during year. We do, however, recommend that you submit your request as early as possible. To ensure adequate opportunity for review, decisions are made on a case-by-case basis. You will usually hear back from Genentech prior to the project/program start date.

Letter of Agreement (LOA)

All grants must abide by the terms in the Genentech Letter of Agreement (LOA), which is issued to an authorized signer of your organization once the application is approved. You must agree to the terms of the LOA before any funding is issued. If you have any questions on the agreement terms, please contact us at (877) 313-5778.

Post Payment Actions

  • You will be asked to provide a project status update and program outcomes throughout the course of the program development and implementation. This can be accessed on the homepage of the grant management application system after you log in.
  • When your project end date has passed, you will receive an email requesting that you reconcile your projected budget with actual expenditures. You must supply reconciliation information within 90 days of the request.

Note: The funding application site does not support IE8 or earlier